CN107941967B - Fingerprint detection method of xiaokeling tablets and xiaokeling capsules - Google Patents
Fingerprint detection method of xiaokeling tablets and xiaokeling capsules Download PDFInfo
- Publication number
- CN107941967B CN107941967B CN201810023255.8A CN201810023255A CN107941967B CN 107941967 B CN107941967 B CN 107941967B CN 201810023255 A CN201810023255 A CN 201810023255A CN 107941967 B CN107941967 B CN 107941967B
- Authority
- CN
- China
- Prior art keywords
- xiaokeling
- solution
- test
- chromatogram
- fingerprint
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a fingerprint detection method of xiaokeling tablets and xiaokeling capsules, which adopts a high performance liquid fingerprint detection method to efficiently detect characteristic peaks of various components such as moutan bark, medlar, astragalus, rehmannia root, coptis in the xiaokeling tablets and the xiaokeling capsules so as to judge whether enterprises have behaviors of no feeding or less feeding and feeding of inferior medicine materials, and can better control the feeding quantity and quality.
Description
Technical Field
The invention relates to the technical field of detection of traditional Chinese medicine preparations, in particular to a fingerprint detection method of xiaokeling tablets and xiaokeling capsules.
Background
The preparation method comprises decocting five materials including rehmanniae radix, radix Ophiopogonis, fructus Schisandrae chinensis, radix astragali, cortex moutan, Coptidis rhizoma, Poria, Ginseng radix Rubri, Trichosanthis radix, fructus Lycii and Gypsum Fibrosum in water for 2 times, concentrating into soft extract, mixing with the rest fine powders, drying, mixing with other adjuvants, granulating, and making into tablet or capsule. Has the effects of supplementing qi and nourishing yin, clearing heat and purging fire, promoting the production of body fluid and quenching thirst.
The existing standard mainly comprises the first part of 'Chinese pharmacopoeia' 2015 edition and the standard YBZ06282004 of the national food and drug administration, wherein microscopic and thin-layer chromatography identification is adopted in the standard to control only poria cocos, gypsum, coptis chinensis, wolfberry and other medicinal materials, and a plurality of medicinal materials lack effective control indexes.
Disclosure of Invention
The invention aims to provide a fingerprint detection method for xiaokeling tablets and xiaokeling capsules, which adopts a high performance liquid fingerprint detection method to efficiently detect characteristic peaks of various components such as moutan bark, medlar, astragalus, rehmannia root, coptis in the xiaokeling tablets and the xiaokeling capsules so as to judge whether enterprises have behaviors of no feeding or less feeding and feeding of inferior medicine materials, and can better control the feeding quantity and quality.
The fingerprint detection method of the diabetes tablet and the diabetes capsule comprises the following steps:
(1) chromatographic conditions and system applicability test, i.e., HICHROM Alltima C18 (250mm × 4.6.6 mm, 5 μm), acetonitrile as a mobile phase A, 0.01 mol/L monopotassium phosphate (PH adjusted to 3 by phosphoric acid) as a mobile phase B, gradient elution is carried out according to the table 1, the detection wavelength is 240nm, and the number of theoretical plates is not less than 10000 calculated according to paeoniflorin peaks.
TABLE 1 gradient elution Table
(2) The preparation of the test solution comprises taking a proper amount of sample, grinding, taking about 3g, precisely weighing, placing in a conical flask, precisely adding 100m L of methanol, weighing, heating and refluxing for 60 min, cooling, weighing again, supplementing the lost weight with methanol, shaking up, filtering, precisely absorbing the subsequent filtrate 50m L, concentrating under reduced pressure to dryness, diluting with 90% methanol to volume of 10m L, shaking up, and filtering.
(3) The control solution is prepared by precisely weighing appropriate amount of penoniflorin control, and adding methanol to obtain solution containing penoniflorin 30 μ g per 1m L.
(4) Establishing a comparison fingerprint.
(5) Methodological tests were performed, which included the following:
1) determining the attribution of chromatographic peaks;
2) testing the stability of the tested solution;
3) testing the precision of the instrument;
4) and (5) performing repeatability test.
(6) And (3) sample determination, namely precisely absorbing 10 mu L of each of the reference solution and the test solution according to chromatographic conditions, injecting the reference solution and the test solution into a liquid chromatograph, recording a 35-minute chromatogram, removing the chromatographic peak in the first 4 minutes, wherein the test chromatogram is basically consistent with the reference fingerprint and has 8 corresponding characteristic peaks, and the characteristic peak is an S peak relative to paeoniflorin.
The invention has the beneficial effects that:
the invention adopts a high performance liquid fingerprint detection method, can efficiently detect characteristic peaks of various components such as moutan bark, medlar, astragalus, rehmannia root, coptis in the diabetes tablet and the diabetes capsule, so as to judge whether the enterprise has the behavior of no feeding or less feeding and feeding of inferior medicine, and can better control the feeding quantity and quality.
Drawings
FIG. 1 is a high performance liquid chromatography fingerprint of lot ZKA1603 sample of company A;
FIG. 2 is a chromatogram of Xiaokeling tablet sample and rehmannia root;
FIG. 3 is a chromatogram of Xiaokeling tablet sample and fructus Lycii;
FIG. 4 is a chromatogram of Xiaokeling tablet sample and radix astragali;
FIG. 5 is an overlay of all manufacturer samples.
Detailed Description
In order to describe the present invention in more detail, the present invention will be further described with reference to the following examples.
Example 1
A fingerprint detection method for XIAOKELING tablet and XIAOKELING Capsule comprises the following steps:
instrument and reagent
Agilent 1260 high performance liquid chromatograph equipped with DAD detector, model M L204 electronic analytical balance (Metler-Tollido instruments Shanghai Co., Ltd.), Hei-VAP type rotary evaporator (Heidolph, Germany).
Paeoniflorin (provided by China institute for testing and testing food and drug, batch number: 110736-201741, content 95.7%);
acetonitrile and potassium dihydrogen phosphate reagents are chromatographically pure, and other reagents are analytically pure;
the samples of the xiaokeling tablets and the xiaokeling capsules are samples of national evaluative spot tests in 2017 years;
the diabetes tablet used in the methodology test is company A, batch number: ZKA 1603.
The detection method comprises the following steps:
(1) chromatographic conditions and system applicability test, i.e., HICHROM Alltima C18 (250mm × 4.6.6 mm, 5 μm), acetonitrile as a mobile phase A, 0.01 mol/L monopotassium phosphate (PH adjusted to 3 by phosphoric acid) as a mobile phase B, gradient elution is carried out according to the table 1, the detection wavelength is 240nm, and the number of theoretical plates is not less than 10000 calculated according to paeoniflorin peaks.
TABLE 1 gradient elution Table
(2) The preparation of the test solution comprises taking a proper amount of sample, grinding, taking about 3g, precisely weighing, placing in a conical flask, precisely adding 100m L of methanol, weighing, heating and refluxing for 60 min, cooling, weighing again, supplementing the lost weight with methanol, shaking up, filtering, precisely absorbing the subsequent filtrate 50m L, concentrating under reduced pressure to dryness, diluting with 90% methanol to volume of 10m L, shaking up, and filtering.
(3) The control solution is prepared by precisely weighing appropriate amount of penoniflorin control, and adding methanol to obtain solution containing penoniflorin 30 μ g per 1m L.
(4) Establishing a contrast fingerprint spectrum: the sample of company A has more batches in the sampling, and 111 batches in total indicate that the sample has larger market share; the standard used by the sample of the company B is a national food and drug administration standard YBZ06282004, the standard collects the content determination of berberine hydrochloride, the control index is more than that of the current pharmacopoeia, and the experiment shows that the quality of the samples of the two enterprises is stable, so the samples of the two enterprises are generated by contrasting fingerprint spectrums. See fig. 1.
(5) Methodological tests were performed, which included the following:
1) chromatographic peak assignment
Comparing the chromatogram of XIAOKELING tablet with chromatogram of rehmanniae radix, fructus Lycii and radix astragali respectively, as shown in fig. 2-4, and the chromatogram peaks are shown in table 2.
TABLE 2 assignment table of various spectral peaks of Xiaokeling tablets
2) Stability test of the tested solutions: taking the same sample solution (ZKA 1603 of A company), measuring the sample solution once at regular intervals according to chromatographic conditions, investigating for 24 hours totally, measuring for 7 times, introducing the measured spectrum into a traditional Chinese medicine chromatographic fingerprint similarity evaluation system recommended by the national pharmacopoeia, taking a paeoniflorin peak as a reference peak, calculating by software, and obtaining the result that the average similarity between the fingerprint of the sample solution and the fingerprint of a reference substance is 0.990 and the RSD is 0.49% (n is 7) in 7 times of measurement, which is shown in Table 3. The test shows that the test solution is stable for at least 24 hours.
Table 3 stability test results
3) Precision test of instrument
The same sample solution (ZKA 1603, company A) was taken and subjected to 6-time continuous measurement under chromatographic conditions. The measured spectrum is introduced into a traditional Chinese medicine chromatogram fingerprint similarity evaluation system recommended by the national pharmacopoeia, the paeoniflorin peak is taken as a reference peak, the software calculates, and the average similarity of the fingerprint of the sample to be measured and the fingerprint of the reference substance is 0.989 and RSD is 0.20 percent (n is 6) in 6 times of measurement results, which is shown in table 4. The test shows that the instrument precision of the method is good.
TABLE 4 results of precision test
4) Repeatability test
Taking the same sample solution (ZKA 1603 of A company), parallelly measuring 6 parts according to chromatographic conditions, introducing the measured spectrum into a traditional Chinese medicine chromatographic fingerprint similarity evaluation system recommended by the national pharmacopoeia, taking a paeoniflorin peak as a reference peak, calculating by software, and obtaining the result that the average similarity between the sample spectrum and the reference fingerprint is 0.991 and the RSD is 0.46% (n is 6) after 6 times of measurement, which is shown in Table 5. Test results show that the method has good reproducibility.
TABLE 5 results of the repeatability tests
(6) The sample determination comprises precisely absorbing 10 mu L of a reference solution and a test solution respectively according to chromatographic conditions, injecting into a liquid chromatograph, recording 35-minute chromatogram, removing the chromatogram peak of the previous 4 minutes, wherein the chromatogram of the test solution is basically consistent with the reference fingerprint, has 8 corresponding characteristic peaks, and is an S peak relative to paeoniflorin, determining the fingerprint of 111 batches of xiaokeling tablets and two batches of xiaokeling capsules of different manufacturers, summarizing all samples, and showing the results in tables 6-8, and showing the overlapped graph of the samples of each manufacturer in figure 4.
TABLE 6 summary of similarity of various manufacturers
TABLE 7 Xiaokeling capsule similarity results
TABLE 8 summary of fingerprint disqualification results for all sampled samples
Claims (1)
1. The fingerprint detection method of the xiaokeling tablets and the xiaokeling capsules is characterized by comprising the following steps:
(1) chromatographic conditions and system applicability tests comprise that the HICHROM Altima C18 takes acetonitrile as a mobile phase A and 0.01 mol/L monopotassium phosphate as a mobile phase B, wherein the pH of the 0.01 mol/L monopotassium phosphate is adjusted to 3 by phosphoric acid, gradient elution is carried out for 57 minutes, the elution procedure is 0-16 min, 5% A → 23% A, 16-35 min, 23% A → 30% A, 35-50 min, 30% A → 48% A, 50-51 min, 48% A → 5% A, 51-57 min, 5% A, the detection wavelength is 240nm, and the number of theoretical plates is not less than 10000 calculated according to paeoniflorin peaks;
(2) preparing a test solution, namely taking a proper amount of samples, grinding, taking 3g of the samples, precisely weighing, placing the samples in a conical flask, precisely adding 100m L of methanol, weighing, heating and refluxing for 60 minutes, cooling, weighing again, supplementing the lost weight with the methanol, shaking up, filtering, precisely absorbing 50m L of a subsequent filtrate, concentrating the filtrate under reduced pressure to dryness, fixing the volume to 10m L with 90% of methanol, shaking up, and filtering to obtain the test solution;
(3) preparing control solution by precisely weighing appropriate amount of penoniflorin control, and adding methanol to obtain solution containing penoniflorin 30 μ g per 1m L;
(4) establishing a comparison fingerprint spectrum;
(5) methodological tests were performed, which included the following:
1) determining the attribution of chromatographic peaks: comparing the chromatogram of XIAOKELING tablet with the chromatogram of rehmanniae radix, fructus Lycii and radix astragali respectively;
2) testing the stability of the tested solution;
3) testing the precision of the instrument;
4) performing a repeatability test;
(6) and (3) sample determination, namely precisely absorbing 10 mu L of the reference solution and the test solution respectively according to chromatographic conditions, injecting the reference solution and the test solution into a liquid chromatograph, recording a 35-minute chromatogram, removing the chromatographic peak in the first 4 minutes, wherein the test chromatogram is basically consistent with the reference fingerprint and has 8 corresponding characteristic peaks, and the characteristic peak is an S peak relative to paeoniflorin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810023255.8A CN107941967B (en) | 2018-01-10 | 2018-01-10 | Fingerprint detection method of xiaokeling tablets and xiaokeling capsules |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810023255.8A CN107941967B (en) | 2018-01-10 | 2018-01-10 | Fingerprint detection method of xiaokeling tablets and xiaokeling capsules |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107941967A CN107941967A (en) | 2018-04-20 |
CN107941967B true CN107941967B (en) | 2020-08-04 |
Family
ID=61938578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810023255.8A Active CN107941967B (en) | 2018-01-10 | 2018-01-10 | Fingerprint detection method of xiaokeling tablets and xiaokeling capsules |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107941967B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1538172A (en) * | 2003-04-17 | 2004-10-20 | 江苏康缘药业股份有限公司 | Quality control method for Chinese medicinal preparation |
WO2006064583A1 (en) * | 2004-12-17 | 2006-06-22 | Use-Techno Corporation | Terpene, method for determining its blood concentration, and method for analyzing its pharmacokinetics |
CN102841154A (en) * | 2012-09-24 | 2012-12-26 | 上海和黄药业有限公司 | Quality testing method of Ganshao Xiaoke tablets |
CN104155371A (en) * | 2013-05-15 | 2014-11-19 | 广州白云山中一药业有限公司 | HPLC (High Performance Liquid Chromatography) fingerprint spectrum of Chinese herbal medicine compound preparation, namely fluid promoting pills, for treating diabetes and establishing method thereof |
CN104614450A (en) * | 2013-11-01 | 2015-05-13 | 天士力制药集团股份有限公司 | Fingerprint detection method of Xiaokeqing preparation |
-
2018
- 2018-01-10 CN CN201810023255.8A patent/CN107941967B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1538172A (en) * | 2003-04-17 | 2004-10-20 | 江苏康缘药业股份有限公司 | Quality control method for Chinese medicinal preparation |
WO2006064583A1 (en) * | 2004-12-17 | 2006-06-22 | Use-Techno Corporation | Terpene, method for determining its blood concentration, and method for analyzing its pharmacokinetics |
CN102841154A (en) * | 2012-09-24 | 2012-12-26 | 上海和黄药业有限公司 | Quality testing method of Ganshao Xiaoke tablets |
CN104155371A (en) * | 2013-05-15 | 2014-11-19 | 广州白云山中一药业有限公司 | HPLC (High Performance Liquid Chromatography) fingerprint spectrum of Chinese herbal medicine compound preparation, namely fluid promoting pills, for treating diabetes and establishing method thereof |
CN104614450A (en) * | 2013-11-01 | 2015-05-13 | 天士力制药集团股份有限公司 | Fingerprint detection method of Xiaokeqing preparation |
Non-Patent Citations (4)
Title |
---|
Qualitative and quantitative analysis of curcuminoids in herbal medicines derived from Curcuma species;Rui Li 等;《Food Chemistry》;20101210;第126卷(第4期);第1890-1895页 * |
RP-HPLC法测定消渴通络胶囊中芍药苷的含量;林荣锋 等;《中药新药与临床药理》;20090131;第20卷(第1期);第61-63页 * |
牡丹皮高效液相色谱指纹图谱研究;许舜军 等;《中国中药杂志》;20061031;第31卷(第20期);第1677-1680页 * |
甘芍消渴片的HPLC指纹图谱;胡春湘 等;《中国医药工业杂志》;20131231;第44卷(第7期);第709-711页 * |
Also Published As
Publication number | Publication date |
---|---|
CN107941967A (en) | 2018-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112098556B (en) | Detection method of angelica sinensis Liuhuang decoction | |
CN103728387A (en) | Shenqi hypoglycemic preparation HPLC standard finger print and construction method thereof | |
CN109187796B (en) | Quality detection and identification method of cortex mori radicis and honey cortex mori radicis decoction pieces | |
CN107402265B (en) | Detection method of Kangyun granule fingerprint | |
CN108362790B (en) | Method for constructing HPLC (high Performance liquid chromatography) characteristic spectrum of Chinese patent medicine' Qingyidan granules | |
CN114152686A (en) | Fingerprint construction method and application of traditional Chinese medicine compound containing cinnamon | |
CN114152687B (en) | Fingerprint construction method and application of traditional Chinese medicine compound containing lotus seeds | |
CN105486762B (en) | A kind of high-efficiency liquid-phase fingerprint detection method of female clever ball | |
CN110031564B (en) | Quality detection method of natural plant anticoccidial feed additive based on HPLC fingerprint | |
CN112763597B (en) | Multi-index content determination method for astragalus root, dendrobium stem and hawthorn granules | |
CN101084974B (en) | Quality control method for codonopsis pilosula | |
CN113686989A (en) | Method for constructing characteristic spectrum of Weixuening granules | |
CN107941967B (en) | Fingerprint detection method of xiaokeling tablets and xiaokeling capsules | |
CN112034085A (en) | HPLC fingerprint detection method for liver-soothing, stomach-harmonizing and pain-relieving traditional Chinese medicine | |
CN114563511B (en) | Detection method of bupleurum, cassia twig and dried ginger decoction | |
CN106501397B (en) | The method for building up and purposes for the treatment of osteoporosis preparation HPLC fingerprint pattern | |
CN110907574B (en) | Quality control method, quality control spectrogram and construction method of traditional Chinese medicine composition | |
CN103257191A (en) | Method for assaying kidney tonifying and life lengthening capsule fingerprint | |
CN110031577B (en) | Quality detection method and identification application of traditional Chinese medicine or traditional Chinese medicine composition preparation | |
CN113252826A (en) | HPLC fingerprint detection method of hypnotic brain-nourishing oral liquid | |
CN108845040B (en) | Method for identifying whether Laijin pills contain pseudo-cynanchum atratum and old melon heads | |
CN111103385A (en) | Fingerprint spectrum determination method of ginseng-prevention and itching-relieving granules | |
CN101785806B (en) | Measurement method of paeoniflorin content in ginseng and astragalus stomach strengthening granules | |
CN114636760A (en) | Fingerprint spectrum establishment method and application of traditional Chinese medicine composition for treating kidney diseases | |
CN108562656B (en) | Method for measuring content of alkaloid and paeonol in traditional Chinese medicine preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |